Jon B. Toledo

Active 2008–2025

89
Papers
21,651
Citations
69
h-index
86
i10-index

Citations

Citations per year for Jon B. Toledo1967: 1 citations1991: 1 citations2001: 2 citations2002: 1 citations2004: 2 citations2006: 9 citations2008: 5 citations2009: 12 citations2010: 9 citations2011: 13 citations2012: 40 citations2013: 124 citations2014: 205 citations2015: 246 citations2016: 273 citations2017: 359 citations2018: 397 citations2019: 1,159 citations2020: 1,325 citations2021: 1,340 citations2022: 1,183 citations2023: 901 citations2024: 1,351 citations2025: 676 citations2026: 21 citations1968–1990: no citations, so these years are not shown1992–2000: no citations, so these years are not shown2003: no citations, so this year is not shown2005: no citations, so this year is not shown2007: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,512 citing papers, 24.2% of this breakdownUnited Kingdom: 1,538 citing papers, 10.6% of this breakdownChina: 968 citing papers, 6.7% of this breakdownGermany: 862 citing papers, 5.9% of this breakdownItaly: 707 citing papers, 4.9% of this breakdownSweden: 647 citing papers, 4.4% of this breakdownCanada: 601 citing papers, 4.1% of this breakdownSpain: 575 citing papers, 4% of this breakdownNetherlands: 542 citing papers, 3.7% of this breakdownAustralia: 473 citing papers, 3.3% of this breakdownFrance: 463 citing papers, 3.2% of this breakdownJapan: 390 citing papers, 2.7% of this breakdown
0%24.2%Other 22.3%

Fields

  • Medicine70.7%
  • Neuroscience12.6%
  • Biochemistry, Genetics and Molecular Biology12.1%
  • Computer Science1%
  • Environmental Science0.5%
  • Psychology0.5%
  • Other2.6%

Topics

  • Alzheimer's disease research and treatments13.2%
  • Dementia and Cognitive Impairment Research10.3%
  • Parkinson's Disease Mechanisms and Treatments7.3%
  • Amyotrophic Lateral Sclerosis Research4.6%
  • Neurological disorders and treatments2.9%
  • Functional Brain Connectivity Studies2.7%
  • Other59%

Coauthors

All papers

Open in search
  1. Diagnosis and management of dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Álex Iranzo, Kejal Kantarci, Daniel Kaufer, Walter A. Kukull, Virginia M.‐Y. Lee, James B. Leverenz, Simon J.G. Lewis, Carol F. Lippa, Angela Lunde, Mario Masellis, Eliezer Masliah, Pamela J. McLean, Brit Mollenhauer, Thomas J. Montine, Emilio Moreno, Etsuro Mori, Melissa E. Murray, John T. O’Brien, Sotoshi Orimo, Ronald B. Postuma, Shankar Ramaswamy, Owen A. Ross, David P. Salmon, Andrew Singleton, Angela Taylor, Alan Thomas, Pietro Tiraboschi, Jon B. Toledo, John Q. Trojanowski, Debby W. Tsuang, Zuzana Walker, Masahito Yamada, Kenji Kosaka - Neurology 2017 cited by 4,446

  2. Primary age-related tauopathy (PART): a common pathology associated with human aging

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alberto Serrano‐Pozo, Michael L. Shelanski, Thor D. Stein, Masaki Takao, Dietmar Rudolf Thal, Jon B. Toledo, Juan C. Troncoso, Jean Paul Vonsattel, Charles L. White, Thomas Wısnıewskı, Randall L. Woltjer, Masahito Yamada, Peter T. Nelson - Acta Neuropathologica 2014 cited by 1,507

  3. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael W. Weiner, P. Murali Doraiswamy, Cornelia M. van Duijn, Andrew J. Saykin, Gabi Kastenmüller, Rima Kaddurah‐Daouk - Alzheimer s & Dementia 2018 cited by 694

  4. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2021 cited by 276

  5. Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2013 cited by 1,066

  6. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre

    Authors: , , , , , , , , - Brain 2013 cited by 863

  7. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giorgio Giaccone, Kimmo J. Hatanpaa, Richard Heale, Patrick R. Hof, Monika Hofer, Tibor Hortobágyi, K. A. Jellinger, Gregory A. Jicha, Paul G. Ince, Julia Kofler, Enikò Kövari, Jillian J. Kril, David Mann, Radoslav Matěj, Ann C. McKee, Catriona McLean, Ivan Milenković, Thomas J. Montine, Shigeo Murayama, Edward B. Lee, Jasmin Rahimi, Roberta Diehl Rodriguez, Annemieke J.M. Rozemüller, Julie A. Schneider, Christian Schultz, William W. Seeley, Danielle Seilhean, Colin Smith, Fabrizio Tagliavini, Masaki Takao, Dietmar Rudolf Thal, Jon B. Toledo, Markus Tolnay, Juan C. Troncoso, Harry V. Vinters, Serge Weis, Stephen B. Wharton, Charles L. White, Thomas Wısnıewskı, John Woulfe, Masahito Yamada, Dennis W. Dickson - Acta Neuropathologica 2015 cited by 530

  8. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study

    Authors: , , , , , , , , , , , , , , , , , , - PLoS Medicine 2018 cited by 499

  9. Metabolic network failures in Alzheimer's disease: A biochemical road map

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Arthur Moseley, Kuixi Zhu, Marc Henrion, Sven J. van der Lee, Amy C. Harms, Ayşe Demirkan, Thomas Hankemeier, Cornelia M. van Duijn, John Q. Trojanowski, Leslie M. Shaw, Andrew J. Saykin, Michael W. Weiner, P. Murali Doraiswamy, Rima Kaddurah‐Daouk - Alzheimer s & Dementia 2017 cited by 496

  10. Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xianlin Han, Rebecca Baillie, Oliver Fiehn, Dinesh Kumar Barupal, Peter J. Meikle, Sarkis K. Mazmanian, Mitchel A. Kling, Leslie M. Shaw, John Q. Trojanowski, Jon B. Toledo, Cornelia van Duijin, Thomas Hankemier, Ines Thiele, Almut Heinken, Nathan D. Price, Cory C. Funk, Priyanka Baloni, Wei Jia, David S. Wishart, Roberta Dı́az Brinton, Rui Chang, Lindsay A. Farrer, Rhoda Au, Wendy Qiu, Peter Würtz, Lara M. Mangravite, Jan Krumsiek, John W. Newman, Bin Zhang, Herman Moreno, Rima Kaddurah‐Daouk, Nathan D. Price - Cell Reports Medicine 2020 cited by 210

  11. Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design

    Authors: , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2022 cited by 95

  12. White matter hyperintensities and imaging patterns of brain ageing in the general population

    Authors: , , , , , , , , , , , , , , , , , , - Brain 2016 cited by 429

  13. Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 213

  14. Dysregulation of the epigenetic landscape of normal aging in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , - Nature Neuroscience 2018 cited by 380

  15. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2018 cited by 258

  16. The Brain Chart of Aging: Machine‐learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2020 cited by 176

  17. Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays

    Authors: , , , , , , , , , , , - Scientific Reports 2019 cited by 203

  18. Neuropathologic substrates of Parkinson disease dementia

    Authors: , , , , , , , , , , , - Annals of Neurology 2012 cited by 535

  19. Elevated CSF GAP‐43 is Alzheimer's disease specific and associated with tau and amyloid pathology

    Authors: , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2018 cited by 211

  20. Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology

    Authors: , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2015 cited by 182

  21. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Brás, Sotoshi Orimo, Mario Masellis, Alan Thomas, Álex Iranzo, Kejal Kantarci, John T. O’Brien, Omar M. A. El‐Agnaf, Bradley F. Boeve, James B. Leverenz, Jon B. Toledo, John E. Duda, Dag Aarsland, David J. Burn, Dennis W. Dickson, Hiroshige Fujishiro, John‐Paul Taylor, F. Blanc, Melissa E. Murray, Brit Mollenhauer, David P. Salmon, Laura Bonanni, Ronald B. Postuma, Emilio Moreno, Virginia M.‐Y. Lee, Debby W. Tsuang, Neill R. Graff‐Radford, Tanis J. Ferman, Douglas Galasko, Patrik Brundin, Simon J.G. Lewis, Zuzana Walker, Ian G. McKeith - 2017 cited by 379

  22. Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

    Authors: , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2018 cited by 176

  23. Characterizing the human hippocampus in aging and Alzheimer's disease using a computational atlas derived from ex vivo MRI and histology

    Authors: , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proc. Natl. Acad. Sci. USA 2018 cited by 216

  24. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord

    Authors: , , , , , , , , , , , , , , , , - Acta Neuropathologica 2014 cited by 288